Alpha 1 Antitrypsin Deficiency Treatment Market Is Estimated to Reach a Valuation of US$ 2,908.1 Million by the End of 2025
The demand in the global alpha-1 antitrypsin deficiency treatment market is projected to increment at an admirable CAGR of 10.3% during the forecast period of 2017 to 2025, gaining traction from a number of factors such as improvements in the diagnostics of alpha-1 antitrypsin deficiency, improving economic scenario in various emerging economies, ample of opportunities in the development of new products, and high unmet demand across the globe. On the other hand, stringent regulations, high cost of drugs, and limited...
View full press release